ClinVar Miner

Submissions for variant NM_138694.4(PKHD1):c.6442G>T (p.Glu2148Ter)

dbSNP: rs1782990176
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Department of Pathology and Laboratory Medicine, Sinai Health System RCV001292356 SCV001480736 pathogenic Polycystic kidney disease no assertion criteria provided clinical testing The PKHD1 p.Glu2148X variant was not identified in the literature nor was it identified in the following databases: dbSNP, ClinVar, LOVD 3.0, or RWTH AAachen University ARPKD database. The variant was not identified in control databases: the 1000 Genomes Project, the NHLBI GO Exome Sequencing Project, the Exome Aggregation Consortium (August 8th 2016), or the Genome Aggregation Database (Feb 27, 2017). The p.Glu2148X variant leads to a premature stop codon at position 2148, which is predicted to lead to a truncated or absent protein and loss of function. Loss of function variants of the PKHD1 gene are an established mechanism of disease in autosomal recessive polycystic kidney disease and is the type of variant expected to cause the disorder. In summary, based on the above information this variant meets our laboratory’s criteria to be classified as pathogenic

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.